Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Cell Immunol. 2021 Mar 1;363:104317. doi: 10.1016/j.cellimm.2021.104317

Table 1.

Characteristics of both cancer patients and normal donors (controls).

Cancer Patient Controls

Age 64±3 35±12
Gender (Male:Female) 14/7 5/5
Platelet Count (103/mm3) 248±21 159±59
Neutrophils 68±3 62±9
Monocytes 9.4±0.6 7.6±1.9
Lymphocytes 19±2 22±9.9
Neoadjuvant (Yes/No) 8/13
Grade
1 4/21
2 3/21
3 3/21
4 2/21
Not Graded 9/21